Since the first gene therapy experiment in 1990, treating two infants with severe combined immunodeficiency (SCID) due to ADA deficiency, gene therapy has been explored and used for various inherited and acquired diseases [212]. The gene discussed is ADA; the disease is severe combined immunodeficiency.